The U.S. Food and Drug Administration (FDA) issued a warning on Thursday, stating that numerous units of counterfeit Ozempic have been seized. While the agency continues to investigate, it cautions that some fraudulent units of the diabetes drug, produced by Novo Nordisk, may still be circulating in the market.

To determine the quality and safety of the seized products, both Novo Nordisk and the FDA are conducting tests. It is important to note that these counterfeit products also feature counterfeit needles, which pose a serious risk of infection due to the inability to confirm their sterility.

Patients are strongly advised to examine all received products and cross-reference the lot and serial numbers listed on the FDA's website with those associated with the counterfeit products.

Regrettably, at least five adverse events have been reported in connection with these counterfeit products. These incidents align with typical side effects of genuine Ozempic, such as nausea and vomiting.

In response to this concerning issue, Novo Nordisk released a statement expressing their dedication to combatting counterfeit products and unlawful activities within the market. They have vowed to collaborate with the FDA in order to identify any potential imitation products in the United States.

Patient safety remains of utmost importance, and both the FDA and Novo Nordisk are taking swift action to address this critical situation.

Alphabet Inc. Cl A Shares Rally on Positive Trading Session

Increases in Holdings

Leave A Reply

Your email address will not be published. Required fields are marked *

Related posts

Stadler Rail Reports Strong Performance in First Half
News

Stadler Rail Reports Strong Performance in First Half

Shares of Stadler Rail surge after strong performance with increased free cash flow and solid order intake.

Stellantis Invests $1.6 Billion in Chinese EV Maker Leapmotor
News

Stellantis Invests $1.6 Billion in Chinese EV Maker Leapmotor

Stellantis invests $1.6 billion in Chinese EV maker Leapmotor, forming a joint venture to bring Chinese-made EVs to the...

Terraform Labs Files for Chapter 11 Bankruptcy Protection
News

Terraform Labs Files for Chapter 11 Bankruptcy Protection

Terraform Labs has filed for chapter 11 bankruptcy protection after the collapse of its digital assets. Co-founder accus...

RTX Corp. Beats Analyst Expectations with Q4 Results
News

RTX Corp. Beats Analyst Expectations with Q4 Results

RTX Corp. surpasses profit and revenue forecasts in Q4, provides optimistic outlook for 2024, and commits to enhancing s...